====== Adult Intracranial Tumor ======

===== Classification =====

[[Intracranial Tumor Classification]]



[[Sub-Saharan Africa]]n (SSA) neuro-oncologists report high [[workload]]s and [[challenge]]s in delivering [[evidence-based]] [[care]]; however, these [[report]]s contrast with modeled estimates of [[adult]] neuro-oncology disease burden in the region. A scoping review aimed to better understand the reasons for this discrepancy by mapping out the SSA adult brain tumor landscape based on published literature.

Systematic searches were conducted in [[OVID]] [[Medline]], [[Global Index Medicus]], African Journals Online, Google Scholar, and faculty of medicine libraries from database inception to May 31 st, 2021. The results were summarized quantitatively and narratively. English and French peer-reviewed articles were included (title, abstract, and full text).

Of the 819 records identified, 119 articles by 24 SSA countries (42.9%) were included in the final review. Odeku published the first article in [[1967]], and nine of the ten most prolific years were in the 21 st century. The greatest contributing region was [[West Africa]] (n=58, 48.7%) led by [[Nigeria]] (n=37, 31.1%). Central Africa had fewer articles published later than the other SSA regions (p=0.61). Most studies were non-randomized (n=75, 63.0%) and meningiomas (n=50, 42.0%) were the most common brain tumors reported. Less than 30 studies reported on adjuvant treatment or patient outcomes.

Most [[publication]]s were hospital-based, and there was significant heterogeneity in the [[quality]] of [[evidence]] and [[report]]ing. This study highlights the need for rapid and sustainable [[investment]]s and [[brain tumor]] [[research]] capacity in SSA
((Kanmounye US, Karekezi C, Nyalundja AD, Awad AK, Laeke T, Balogun JA. Adult brain tumors in Sub-Saharan Africa: A scoping review. Neuro Oncol. 2022 Apr 9:noac098. doi: 10.1093/neuonc/noac098. Epub ahead of print. PMID: 35397473.)).

====== Treatment ======
[[Intracranial tumor treatment]]